Key result
Transcatheter aortic valve replacement is associated with major vascular complications in 10% to 20% of patients, which significantly increases 30-day mortality and hospital length of stay.
Vascular complications are a major source of morbidity and mortality post-TAVR, requiring meticulous preprocedural planning with CTA and prompt recognition for optimal management.
Answers are grounded in this paper and cite their sources.
Vascular complications in TAVR adversely affect outcomes; leaves open optimal mitigation strategies as use expands to lower-risk patients.
Transcatheter aortic valve replacement (TAVR) has rapidly emerged as the standard of care for severe symptomatic aortic stenosis in patients whose comorbidities put them at prohibitive risk for surgical aortic valve replacement (SAVR). Several trials have demonstrated superior outcomes with TAVR compared to medical management alone. TAVR has also shown favorable outcomes in patients at high risk for SAVR. TAVR can be associated with significant vascular complications, which adversely impact outcomes, and operators should be cognizant of their early recognition and appropriate management. In this article, we review the major vascular complications associated with TAVR, along with optimal prevention and management strategies.
No takes yet. Share an insight, caveat, or question.
Mangla et al. (2016) conducted a review in Severe aortic stenosis undergoing TAVR. Transcatheter aortic valve replacement (TAVR) was evaluated. Transcatheter aortic valve replacement is associated with major vascular complications in 10% to 20% of patients, which significantly increases 30-day mortality and hospital length of stay.
Synapse has enriched 10 related papers. Consider them for comparative context: